E Fund Management Co., Ltd. Novavax Inc Transaction History
E Fund Management Co., Ltd.
- $1.6 Billion
- Q1 2024
A detailed history of E Fund Management Co., Ltd. transactions in Novavax Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 79,514 shares of NVAX stock, worth $946,216. This represents 0.02% of its overall portfolio holdings.
Number of Shares
79,514
Previous 86,558
8.14%
Holding current value
$946,216
Previous $415,000
8.43%
% of portfolio
0.02%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding NVAX
# of Institutions
243Shares Held
76.1MCall Options Held
5.06MPut Options Held
7.19M-
State Street Corp Boston, MA16.9MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$161 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.43MShares$112 Million0.0% of portfolio
-
Shah Capital Management8.12MShares$96.6 Million19.75% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$30.8 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $931M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...